These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 27552553)

  • 1. Quality of life of HIV-infected patients who switch antiretroviral medication due to side effects or other reasons.
    Maiese EM; Johnson PT; Bancroft T; Goolsby Hunter A; Wu AW
    Curr Med Res Opin; 2016 Dec; 32(12):2039-2046. PubMed ID: 27552553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of neuropsychiatric symptoms related to an antiretroviral drug following its substitution by nevirapine: the RELAX study.
    Pedrol E; Llibre JM; Tasias M; Currán A; Guardiola JM; Deig E; Guelar A; Martínez-Madrid O; Tikhomirova L; Ramírez R;
    HIV Med; 2015 Nov; 16(10):628-34. PubMed ID: 26238151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-reported outcomes in virologically suppressed, HIV-1-Infected subjects after switching to a simplified, single-tablet regimen of efavirenz, emtricitabine, and tenofovir DF.
    Hodder SL; Mounzer K; Dejesus E; Ebrahimi R; Grimm K; Esker S; Ecker J; Farajallah A; Flaherty JF;
    AIDS Patient Care STDS; 2010 Feb; 24(2):87-96. PubMed ID: 20156091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beliefs about antiretroviral therapy, treatment adherence and quality of life in a 48-week randomised study of continuation of zidovudine/lamivudine or switch to tenofovir DF/emtricitabine, each with efavirenz.
    Cooper V; Moyle GJ; Fisher M; Reilly G; Ewan J; Liu HC; Horne R;
    AIDS Care; 2011 Jun; 23(6):705-13. PubMed ID: 21476152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly active antiretroviral treatment (HAART) and health-related quality of life in naive and pretreated HIV-infected patients.
    Casado A; Consiglio E; Podzamczer D; Badia X
    HIV Clin Trials; 2001; 2(6):477-83. PubMed ID: 11742436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of patient beliefs and treatment satisfaction on the discontinuation of current first-line antiretroviral regimens.
    Casado JL; Marín A; Romero V; Bañón S; Moreno A; Perez-Elías MJ; Moreno S; Rodriguez-Sagrado MA
    HIV Med; 2016 Jan; 17(1):46-55. PubMed ID: 26149493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral treatment and quality of life in Africans living with HIV: 12-month follow-up in Burkina Faso.
    Jaquet A; Garanet F; Balestre E; Ekouevi DK; Azani JC; Bognounou R; Dah E; Kondombo JC; Dabis F; Drabo J
    J Int AIDS Soc; 2013 Dec; 16(1):18867. PubMed ID: 24369739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral Treatment Switching and Its Association With Economic Outcomes and Adverse Treatment Effects Among Commercially Insured and Medicaid-Enrolled Patients With HIV in the United States.
    Korsnes JS; Goodwin BB; Murray M; Candrilli SD
    Ann Pharmacother; 2016 Dec; 50(12):989-1000. PubMed ID: 27439947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life in HIV/AIDS patients on antiretroviral therapy at a tertiary care facility in Zimbabwe.
    Mafirakureva N; Dzingirai B; Postma MJ; van Hulst M; Khoza S
    AIDS Care; 2016 Jul; 28(7):904-12. PubMed ID: 27098289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes health-related quality of life in HIV-infected patients following initiation of antiretroviral therapy: a longitudinal study.
    Dutra BS; Lédo AP; Lins-Kusterer L; Luz E; Prieto IR; Brites C
    Braz J Infect Dis; 2019; 23(4):211-217. PubMed ID: 31344351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life of HIV patients in a rural area of western Uganda: impact of a community-based antiretroviral treatment program.
    Alibhai A; Martin LJ; Kipp W; Konde-Lule J; Saunders LD; Rubaale T; Houston S; Okech-Ojony J
    Curr HIV Res; 2010 Jul; 8(5):370-8. PubMed ID: 20353388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen: a substudy of the randomised, open-label, non-inferiority SECOND-LINE study.
    Boyd MA; Amin J; Mallon PW; Kumarasamy N; Lombaard J; Wood R; Chetchotisakd P; Phanuphak P; Mohapi L; Azwa I; Belloso WH; Molina JM; Hoy J; Moore CL; Emery S; Cooper DA;
    Lancet HIV; 2017 Jan; 4(1):e13-e20. PubMed ID: 27815068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral treatment in pediatric HIV infection in the United States: from clinical trials to clinical practice.
    Brogly S; Williams P; Seage GR; Oleske JM; Van Dyke R; McIntosh K;
    JAMA; 2005 May; 293(18):2213-20. PubMed ID: 15886376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of treatment interruption and intensification of antiretroviral therapy on health-related quality of life in patients with advanced HIV: a randomized, controlled trial.
    Joyce VR; Barnett PG; Chow A; Bayoumi AM; Griffin SC; Sun H; Holodniy M; Brown ST; Kyriakides TC; Cameron DW; Youle M; Sculpher M; Anis AH; Owens DK
    Med Decis Making; 2012; 32(1):70-82. PubMed ID: 21383086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of HIV antiretroviral therapy on depression and mental health among clients with HIV in Uganda.
    Wagner GJ; Ghosh-Dastidar B; Garnett J; Kityo C; Mugyenyi P
    Psychosom Med; 2012; 74(9):883-90. PubMed ID: 22923701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life improvement in HIV-1 patients treated with raltegravir in a real-life observational study: RACING.
    Spire B; Nait-Ighil L; Pugliese P; Poizot-Martin I; Jullien V; Marcelin AG; Billaud E
    HIV Clin Trials; 2017 Jan; 18(1):1-16. PubMed ID: 28125951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reasons for switching ART: Comparison of data collected in 2012-2013 and 2014-2015 in Florence, Italy.
    Fusco FM; Burla MC; Degli Esposti A; Pierotti P; Rabatti L; Vichi F
    Int J STD AIDS; 2018 Mar; 29(4):392-395. PubMed ID: 28853677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reasons and Risk Factors for the Initial Regimen Modification in Chinese Treatment-Naïve Patients with HIV Infection: A Retrospective Cohort Analysis.
    Sun J; Liu L; Shen J; Qi T; Wang Z; Song W; Zhang R; Lu H
    PLoS One; 2015; 10(7):e0133242. PubMed ID: 26207639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switch from zidovudine- to non-zidovudine-containing regimens is associated with modest haematological improvement and no obvious clinical benefit: a substudy of the ANRS 099 ALIZE trial.
    Lafaurie M; Collin F; Bentata M; Garré M; Leport C; Levy Y; Goujard C; Chêne G; Molina JM;
    J Antimicrob Chemother; 2008 Nov; 62(5):1122-9. PubMed ID: 18662943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.